Liq-NOL Efficacy in Pediatric Patients With Down Syndrome

Status Withdrawn

Clinical Trial Summary

The purpose of this study is to measure the effects of LiQ-NOL supplementation on language production using the Clinical Evaluation of Language Fundamentals test, language sampling using the mean length of utterance test, and speech articulation using the Goldman-Fristoe Test of Articulation.

Clinical Trial Description

This is a randomized, double-blind, placebo-controlled clinical study of CoQ efficacy in a crossover design. Patients will be screened, enrolled, and studied in the outpatient clinic of the Thomas Center for Down Syndrome at CCHMC. All patients will be randomly assigned to either a liquid product (LiQ-NOL®) and an identical placebo liquid. Study drug and placebo will be administered twice a day (morning and evening). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00891917
Study type	Interventional
Source	Children's Hospital Medical Center, Cincinnati
Contact
Status	Withdrawn
Phase	Phase 2
Start date	January 2005
Completion date	December 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04854122` - Blood Flow Regulation in Individuals With Down Syndrome - Training Study	N/A
Completed	`NCT04020302` - Self-Monitoring Shopping Intervention	N/A
Recruiting	`NCT01950624` - DS-Connect {TM}: The Down Syndrome Registry
Completed	`NCT04751136` - the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome	Phase 2
Completed	`NCT04767412` - Inspiratory Muscle Training and Physical Fitness in Children With Down Syndrome Randomized Control Trial	N/A
Not yet recruiting	`NCT04037579` - Protocol for a Non-randomized Survey in Down Syndrome People Who Practice Sports. Self and Observers´ Perception.
Completed	`NCT04536506` - Bobath and Vojta Therapy for DS	N/A
Completed	`NCT02882698` - Performance Analysis in Down Syndrome on Mobile Phone	N/A
Completed	`NCT01791725` - A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia	Phase 2
Unknown status	`NCT01975545` - Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21	Phase 2
Completed	`NCT01808508` - Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome	N/A
Terminated	`NCT00754013` - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10	Phase 3
Terminated	`NCT00754052` - Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17	Phase 3
Completed	`NCT01256112` - Parent Supported Weight Reduction in Down Syndrome	N/A
Completed	`NCT01313325` - Hippotherapy to Improve the Balance of Children With Movement Disorders	N/A
Completed	`NCT01594346` - Multicenter Vitamin E Trial in Aging Persons With Down Syndrome	Phase 3
Completed	`NCT05343468` - Life Skills Improved in Children With Down Syndrome After Using Assistive Technology	N/A
Suspended	`NCT05755464` - Evaluation of Patients With Down Syndrome Compliance to Dental Therapy
Recruiting	`NCT04022460` - Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
Completed	`NCT04818437` - Effect of Core Stability Exercises and Balance Training in Postural Control Among Down Syndrome	N/A